This is a proposal for continued NIH/NIGMS support for our COBRE in Stem &Progenitor Cell Biology and Regenerative Medicine as we transition from successful Phase-ll status to a critical stage of Phase-Ill development. Prime goals are: i) Continue to advance thematic, biomedically relevant discoveries in stem and progenitor cell biology;ii) Sustain and extend strong internal and external advisory committees and supporting mechanisms to expertly mentor investigators, fellows, students and core staff;iii) Implement a Pilot Project Program to springboard highly promising discoveries towards national funding and impacting publications;iv) Work with our highly supportive Medical Center and Research Institute to recruit additional strong COBRE Center investigators;v) Continue to sharpen the expertise, efficiency, utility and selfsustaining nature of our Center's Research Core Facilities. During Phase-ll, we have further advanced impacting discoveries in our discipline, published studies in excellent journals, mentored and advanced Center investigations, recruited strong new investigators, and demonstrated clear success in securing independent national funding. Gains in infrastructure and Institutional support also are significant. These include the construction of a new research wing, the ongoing recruitment of additional scientists, the advancement of existing core facilities, and the development of a highly needed Physiology Core. In Phase-Ill, the PI will be assisted administratively by a co-lnvestigator (L. Oxburgh, PhD, DVM COBRE member since 2005) and Program Coordinator (E. Jachimowicz). Our administrative core will implement a Pilot Project Program for outstanding seed investigations, and to advance new translational research opportunities;a core workshop and summer symposium in Stem &Progenitor Cell Biology;an invited seminar series;and the recruitment of a magnet clinician scientist. Core facilities also will be enhanced. The Molecular Phenotyping Core focuses on quantitative molecular analysis of gene expression and cellular microscopy. The Histopathology Core provides expert histological support plus new collaborations involving human pathology studies, and mouse genetic mutants. Our Progenitor Cell Analysis Core provides flow cytometric analyses, cell sorting, clonal cell analyses and stem/progenitor cell culture services. Our new Physiology Core will provide state-of-the-art metabolic phenotyping, skeletal imaging and cell energetic analyses. Specific plans towards Core and Center self-sufficiency post- Phase-Ill also are defined.

Public Health Relevance

Phase l &ll COBRE support has enabled marked gains in infrastructure, new faculty positions, mentoring &training, thematic discoveries, and independent national funding. To now transition to a self-sustaining nationally recognized Center, the award of Phase-Ill support is critical to see our Center and its high-utility Core Facilities through to independence as a strongly contributing, nationally recognized Center in Stem &Progenitor Cell Biology.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
1P30GM106391-01
Application #
8514209
Study Section
Special Emphasis Panel (ZGM1-TWD-C (C3))
Program Officer
Douthard, Regine
Project Start
2013-09-01
Project End
2018-05-31
Budget Start
2013-09-01
Budget End
2014-05-31
Support Year
1
Fiscal Year
2013
Total Cost
$1,091,138
Indirect Cost
$359,668
Name
Maine Medical Center
Department
Type
DUNS #
071732663
City
Portland
State
ME
Country
United States
Zip Code
04102
Carvalho, Adriana Lelis; DeMambro, Victoria E; Guntur, Anyonya R et al. (2018) High fat diet attenuates hyperglycemia, body composition changes, and bone loss in male streptozotocin-induced type 1 diabetic mice. J Cell Physiol 233:1585-1600
Muthukrishnan, Sree Deepthi; Ryzhov, Sergey; Karolak, Michele et al. (2018) Nephron progenitor cell death elicits a limited compensatory response associated with interstitial expansion in the neonatal kidney. Dis Model Mech 11:
Prudovsky, Igor; Anunciado-Koza, Rea P; Jacobs, Chester G et al. (2018) Mesoderm-specific transcript localization in the ER and ER-lipid droplet interface supports a role in adipocyte hypertrophy. J Cell Biochem 119:2636-2645
Reifsnyder, Peter C; Ryzhov, Sergey; Flurkey, Kevin et al. (2018) Cardioprotective effects of dietary rapamycin on adult female C57BLKS/J-Leprdb mice. Ann N Y Acad Sci 1418:106-117
Farrell, Mariah L; Reagan, Michaela R (2018) Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma. Front Endocrinol (Lausanne) 9:218
Ryzhov, Sergey; Robich, Michael P; Roberts, Daniel J et al. (2018) ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC). J Mol Cell Cardiol 115:39-50
Yang, Xuehui; Gong, Yan; He, Qing et al. (2018) Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. J Cell Biochem 119:3267-3279
Zaidi, Mone; Lizneva, Daria; Kim, Se-Min et al. (2018) FSH, Bone Mass, Body Fat, and Biological Aging. Endocrinology 159:3503-3514
Zaidi, Mone; Yuen, Tony; Sun, Li et al. (2018) Regulation of Skeletal Homeostasis. Endocr Rev 39:701-718
Sitarski, Anna M; Fairfield, Heather; Falank, Carolyne et al. (2018) 3d Tissue Engineered In Vitro Models Of Cancer In Bone. ACS Biomater Sci Eng 4:324-336

Showing the most recent 10 out of 82 publications